Johnson & Johnson set to begin India trial of its single-shot vaccine, says report – ET HealthWorld

Johnson & Johnson has told Indian regulators that it will soon begin clinical trials of its single-shot Covid-19 vaccine in the country.

The US drugs and healthcare giant has sent a letter to India’s Central Drugs Standard Control Organization (CDSCO) saying it would “very shortly apply for permission to conduct clinical bridging trials in India,” according to the report.

The report comes as many vaccination centers in India grapple with a shortage of vaccine supplies as the country of 1.3 billion is battling a second wave of Covid-19 infections that has eclipsed the first. India’s government, however, has repeatedly said there is no shortage of shots.

India currently has two approved vaccines in use, one developed by Oxford university and AstraZeneca and the other, a shot from local player Bharat Biotech.

There are other vaccine candidates in trials in India including Russia’s Sputnik-v, for which local drugmaker Dr Reddy’s is currently conducting trials. Another shot developed by Cadila Healthcare Ltd is also in trials.

Follow and connect with us on , Facebook, Linkedin


Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Adblock Detected

Please Remove AdBlocker